
The steps taken for the discovery of the hallucinogenic effects of N.N-Dimethyl-tryptamine (DMT) is described. DMT had a difficult first 50 years in medical research primarily for legal reasons as it was classified as one of the "drugs of abuse" by authorities in the USA and by the World Health Organization. It has not proved to be a "schizotoxin" as it was first suspected, but the book is not closed on its potential role in some other, high level function as an endogenous neuromodulator. Further clinical work may even substantiate its usefulness in therapeutic application, such as an adjunct to psychotherapy, perhaps not by itself, but in a modified form, or in combination with other substances.
Clinical Trials as Topic, Hungary, Substance-Related Disorders, World Health Organization, United States, Serotonin Receptor Agonists, N,N-Dimethyltryptamine, Hallucinogens, Schizophrenia, Animals, Humans, Serotonin Antagonists
Clinical Trials as Topic, Hungary, Substance-Related Disorders, World Health Organization, United States, Serotonin Receptor Agonists, N,N-Dimethyltryptamine, Hallucinogens, Schizophrenia, Animals, Humans, Serotonin Antagonists
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 14 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
